Is there a window of opportunity to optimize trastuzumab cardiac monitoring?

doi:10.4330/wjc.v14.i7.403

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4365)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

163

WORD

HTML

1496

Figures (1-2)

237

Tables (1-1)

214

Sum=2152

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

182

Download

713

Sum=895

Publishing Process of This Article

Item

Count

Browse

362

Download

956

Sum=1318

Jul 26, 2022 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Cardiol. Jul 26, 2022; 14(7): 403-410
Published online Jul 26, 2022. doi: 10.4330/wjc.v14.i7.403

Full Size Figure Download Figure

Figure 2 Percentage of cardiac event over time. OR: Odds ratio; CI: Confidence interval.

Citation: Rala de Paula BH, Costa METF, de Sousa CAM, Bines J. Is there a window of opportunity to optimize trastuzumab cardiac monitoring? World J Cardiol 2022; 14(7): 403-410
URL: https://www.wjgnet.com/1949-8462/full/v14/i7/403.htm
DOI: https://dx.doi.org/10.4330/wjc.v14.i7.403